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Innate resistance to Candida albicans in mucosal tis-
sues requires the production of interleukin-17A (IL-
17A) by tissue-resident cells early during infection,
but the mechanism of cytokine production has not
been precisely defined. In the skin, we found that
dermal gd T cells were the dominant source of IL-
17A during C. albicans infection and were required
for pathogen resistance. Induction of IL-17A from
dermal gd T cells and resistance to C. albicans re-
quired IL-23 production from CD301b+ dermal den-
dritic cells (dDCs). In addition, we found that sen-
sory neurons were directly activated by C. albicans.
Ablation of sensory neurons increased susceptibility
to C. albicans infection, which could be rescued by
exogenous addition of the neuropeptide CGRP.
These data define a model in which nociceptive
pathways in the skin drive production of IL-23 by
CD301b+ dDCs resulting in IL-17A production from
gd T cells and resistance to cutaneous candidiasis.
INTRODUCTION
Candida albicans is a common, highly morbid pathogen at barrier
sites such as the skin and oral cavity in the setting of immunosup-
pression. For example, patients with defective T helper 17 (Th17)
cell immunity such as AIDS or hyper-IgE syndrome are prone to
develop chronic mucocutaneous candidiasis (CMC) (McDonald,
2012). Mice with defective Th17 cell type responses are also
moresusceptible tobothoral andcutaneouscandidiasis (Herna´n-
dez-Santos et al., 2013; Kashem et al., 2015). Patients with
autoimmune polyendocrinopathy-candidiasis-ectodermal dys-
trophy (APECED) disorder have circulating neutralizing antibodies
against IL-17 and develop CMC (Kisand et al., 2010; Puel et al.,
2010). Similarly, patients with IL-17 receptor A (IL-17RA) or IL-
17F deficiencies also suffer from CMC (Puel et al., 2011; Smeek-
ens et al., 2011). These patients have global defects in the IL-17
pathway that affects both IL-17 produced by Th17 cells as well
as IL-17 derived from cells of the innate immune system.
It is becoming increasingly clear that innate sources of IL-17
are crucial for host defense against C. albicans at barrier sitesIm(Conti et al., 2014; Gladiator et al., 2013). In the skin, dendritic
epidermal T cells (DETCs), dermal gd T cells, CD4+ and CD8+
ab T cells, and innate lymphoid cells (ILCs) all can produce IL-
17 (Gray et al., 2011; MacLeod et al., 2013; Naik et al., 2015,
2012). IL-17 from dermal gd T cells is required for immunity
against BCG, Staphylococcus aureus, and vaccinia virus and
for autoimmune inflammation (Cho et al., 2010; Gray et al.,
2011, 2013; Sumaria et al., 2011; Woodward Davis et al.,
2015). CD4+ and CD8+ T cells generate IL-17 responses to com-
mensal organisms such as Staphylococcus epidermitis and pro-
tect against opportunistic pathogens (Naik et al., 2012, 2015). In
mouse models of oropharyngeal candidiasis, IL-17 from ab and
gd T cells as well as ILC3smediate protection, though the contri-
bution of each cell type remains controversial (Conti et al., 2014;
Gladiator et al., 2013).
Production of IL-17 by tissue-resident lymphocytes is medi-
ated by pro-inflammatory cytokines, notably IL-23 (Sherlock
et al., 2012; Sutton et al., 2009). IL-23 signaling plays a critical
role against mucocutaneous candidiasis as shown by the fact
that humans with IL-23R signaling defects are prone to CMC
andmicewith IL-23 deficiencies are susceptible to oral and cuta-
neous candidiasis (Gaffen et al., 2014; Kagami et al., 2010;
Smeekens et al., 2011). There are at least three well-defined sub-
sets of cutaneous dendritic cells (DCs): epidermal Langerhans
cells (LCs), CD103+ dermal DCs (dDCs), and CD11b+ DCs (Ka-
plan, 2010). LCs and CD11b+ dDCs both secrete IL-23 and con-
flicting reports suggest that each is an obligate source of IL-23
during imiquimod-induced dermatitis (Wohn et al., 2013; Yoshiki
et al., 2014). Recently, the role of nociceptors has been appreci-
ated in IL-23-mediated imiquimod-induced skin inflammation
(Riol-Blanco et al., 2014). In addition, pathogens such as
S. aureus can directly activate neurons isolated from the dorsal
root ganglion (DRG) and induce pain hyper-responsiveness
(Chiu et al., 2013). The relationship between nociception and
innate immunity, however, remains poorly characterized.
In our previous work, we developed an epicutaneous
C. albicans infection model that does not require immunosup-
pression or dysbiosis for productive infection (Igya´rto´ et al.,
2011). In this model, LCs are not required for pathogen clearance
in naive mice. LCs were necessary and sufficient, however, for
the development of antigen-specific Th17 cells that provided
protection from a secondary infection in immune mice (Kashem
et al., 2015). The cell types and cytokine networks responsible
for resistance to C. albicans in the skin, however, have not
been precisely defined. In this report, we examined the cellularmunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc. 515
sources of IL-17 and the inflammatory cascade that mediated
resistance to cutaneous C. albicans infection in naive mice. We
found that IL-23 from CD301b+ dDCs that includes the CD11b+
dDC subset drove expansion and IL-17 production by dermal
gd T cells, resulting in protection from C. albicans. In addi-
tion, transient receptor potential cation channel subfamily V
member 1 (TRPV1) nociceptive neurons and the neuropeptide
calcitonin gene-related peptide (CGRP) acted upstream of
CD301b+ dDCs to drive IL-23 expression. Thus, we have defined
a sequence of coordinated events occurring early during
C. albicans skin infection that link nociceptive neurons, dendritic
cells, and gd T cells in establishing host defense against a fungal
infection in the skin.
RESULTS
IL-17A from gd T Cells Is Required for Resistance to
Cutaneous Candidiasis
In the oral mucosa, IL-17 from ab T cells, gd T cells, and ILCs has
been reported to be required for resistance to C. albicans infec-
tion (Conti et al., 2014, 2009; Gladiator et al., 2013; Gladiator and
LeibundGut-Landmann, 2013). We have previously described a
model of cutaneous candidiasis in which C. albicans yeast is
applied onto the shaved back skin of immunocompetent mice.
Infection, as measured by CFUs in the skin, peaks 2–3 days
after inoculation but gradually declines over the course of
5 days (Igya´rto´ et al., 2011). To determine whether IL-17 was
required to control infection, we skin-infected mice deficient in
IL-17A and IL-17F production (Il17af/ mice). As expected,
mice lacking IL-17A were highly susceptible to infection and
had higher C. albicans burden 3 days after infection (Figure 1A).
To identify the cellular source of IL-17A, we first analyzed
the composition of the cellular infiltrate found in the skin of in-
fected mice. Lymphoid cells in the skin can be identified by
flow cytometric analysis of collagenase-digested skin gated on
CD90.2+lin (B220, CD11c, CD11b, F4/80) cells as TCRgdhi
TCRblo DETCs, TCRgdmidTCRblo dermal gd T cells, TCRgdlo
TCRbhi ab T cells (including CD4+ and CD8+ T cells), and a TCRlo
population that includesNKand innate lymphoid cells (Figure 1B;
Riol-Blanco et al., 2014). During infection, the numbers of dermal
gd T cells and CD4+ ab T cells were increased compared with
naive mice (Figure 1C). Intracellular flow cytometry revealed
that approximately 3% of the CD90.2+ cells in infected skin ex-
pressed IL-17A (Figure 1D). When we subsetted these cells,
we observed that dermal gd T cells were the dominant source
of IL-17A with a small amount contributed by CD4+TCRb+ cells
(Figure 1E). Individual dermal gd T cells appeared to produce
more IL-17A than CD4+TCRb+ cells based on MFI. DETCs,
CD8+ TCRb+ cells, and CD90.2+TCR innate lymphoid subsets
did not produce appreciable amounts of IL-17.
To determine whether dermal gd T cells and ab T cells were
required for resistance to C. albicans, we skin-infected con-
trol, Rag1/ (lacking both T cell subsets), and Tcra/ (lacking
ab T cells) mice (Figure 1F). Fungal burden was increased in
Rag1/ but not Tcra/ mice, indicating a requirement for gd
T cells. To confirm this finding and exclude any role for DETCs,
we generated mixed bone marrow chimeras in which Tcrd/
bone marrow was transferred into irradiated B6.SJL-Ly5.2
(referred to as CD45.1 WT) hosts. Because DETCs are radio516 Immunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc.resistant, these mice have a selective absence of dermal gd
T cells (unpublished observations) (Honjo et al., 1990). As ex-
pected, Tcrd// CD45.1 WT mice had a significantly higher
fungal burden than the WT/ CD45.1 WT controls (Figure 1G).
These results indicate that resistance to primary C. albicans
skin infection requires IL-17 produced by dermal gd T cells.
IL-17-Producing gd T Cells Require IL-23
We next sought to identify the factors required for production of
IL-17 by dermal gd T cells. In vitro, gd T cell activation has been
shown to require IL-1R and/or IL-23R signaling (Cai et al., 2014;
Gray et al., 2011). Because patients with deficiencies in IL-23
signaling but not IL-1 signaling suffer from chronic mucocuta-
neous candidiasis, we focused on the role of IL-23 in response
to C. albicans infection (Huppler et al., 2012; Smeekens et al.,
2011). Skin infection of IL-23p19-deficient mice (referred to as
Il23a/) resulted in a large reduction of dermal gd T cells
compared with naive controls (Figure 2A). In addition to fewer
cells, there was also a reduced frequency of cells expressing
IL-17, resulting in a dramatic decrease in the number of dermal
gd T cells producing IL-17 (Figures 2B and 2C). Skin infection
with C. albicans was associated with a strong induction of
dermal gd T cell proliferation as evidenced by the large number
of Ki-67-positive cells after infection (Figure 2D). In the absence
of IL-23, proliferation was greatly curtailed, consistent with ob-
servations that IL-23 drives proliferation of gd T cells in vitro
(Cai et al., 2014). Consistent with the importance of IL-17 from
dermal gd T cells, we found that the fungal burden was greatly
increased in Il23a/mice (Figure 2E). Exogenous administration
of IL-17A restored fungal burdens to the level observed in WT
mice, indicating that IL-23 acts upstream of IL-17 (Figure 2E).
These results show that IL-23 is required for proliferation and
production of IL-17A by dermal gd T cells during C. albicans
infection.
IL-23 from CD301b+ Dermal DCs Is Critical for IL-17
Production by Dermal gd T Cells and Pathogen
Resistance
In other models, DCs have been shown to be an important
source of IL-23 (Satpathy et al., 2013; Wohn et al., 2013).
To determine whether IL-23 from DCs was required for cuta-
neous resistance to C. albicans, we skin-infected control and
CD11c-DTR mice 1 day after treatment with diphtheria toxin
(DT) to deplete all dendritic cells. DC-depleted mice expressed
lower amounts of Il23amRNA in the skin 16 hr after infection (Fig-
ure 3A). In addition, DC-deficient mice were unable to clear
C. albicans as efficiently as controls (Figure 3B). These findings
indicate that dendritic cells are a non-redundant source of IL-
23 that is required for clearance of C. albicans skin infection
in vivo.
There are at least three major subsets of DCs in the skin. To
evaluate whether LCs or CD103+ dDCs are an obligate source
of IL-23, we crossed huLangerin-DTA mice that lack LCs
with Batf3/ mice that lack CD103+ dDCs to generate human
Langerin-DTA3Batf3/ mice (referred to as LCDBatf3D) that
lack both DC subsets (Edelson et al., 2010; Kashem et al.,
2015; Welty et al., 2013). Production of IL-23, numbers of dermal
gd T cells, expression of IL-17 by dermal gd T cells, and
C. albicans CFUs were all unaffected by the absence of these
Figure 1. Dermal gd T Cells, but Not ab T Cells, Are Required for IL-17-Mediated Protection against C. albicans
Cohorts of mice were infected on their shaved dorsum with 2 3 108 CFU C. albicans.
(A) Day 3 whole skin homogenates from wild-type or Il17af/ infected mice were plated onto YPAD agar plates and incubated at 30C for 48 hr. The number of
colony-forming units (CFU) per cm2 of skin is shown.
(B) Single-cell suspensions fromwhole skin was obtained by enzymatic digestion and analyzed by flow cytometry gated as singlets, live/dead excluded, CD90.2+,
and Lineage (B220CD11cCD11bF4/80). Expression of TCRb and TCRgd is used to identify lymphoid subsets in the skin.
(C) The numbers in each lymphocyte subset as in (B) in naive (white) and C. albicans-infected (black) mice are shown.
(D) Cells isolated from skin were re-stimulated with PMA and ionomycin in the presence of monensin and gated as in (B). Expression of IL-17A by CD90.2+
lymphocytes is shown.
(E) Representative expression of IL-17A and interferon-g (IFN-g) by individual subsets from (D) are shown.
(F) C. albicans CFUs isolated from the skin of WT, Rag1/, and Tcra/ mice 3 days after infection is shown.
(G) Lethally irradiated B6.SJL-Ly5.2 were reconstituted with bone marrow from WT C57BL/6 or Tcrd/mice and rested for 12 weeks. C. albicans CFUs 3 days
after infection is shown.
Error bars represent mean ± SEM. Student’s unpaired t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Data points in (A), (F), and (G) represent individual
animals. Data are representative of at least three mice per group and at least three independent experiments.DC subsets (Figures 3C–3F). This indicates that CD103+ dDCs
and LCs are not required for innate responses to C. albicans
and that another source of IL-23 is sufficient.
The C-type lectinmacrophage galactose lectin type 2 receptor
(Mgl2; CD301b) is expressed by the bulk of CD103 dDCs in the
dermis and can be ablated with Mgl2-DTR mice (Kashem et al.,
2015; Kumamoto et al., 2013). CD301b+ dDCs are heteroge-
neously comprised of CD11b+CD64 conventional DCs and
the recently defined CD11b+CD64+ cells that are now ontogeni-
cally defined as tissue macrophages (McGovern et al., 2014).
C. albicans infection of Mgl2-DTR mice depleted of CD301b+
DCs by injection of DT showed greatly decreased IL-23 expres-
sion in the skin compared to PBS-treated mice (Figure 3G). In
addition, the numbers of dermal gd T cells and IL-17 productionImby gd T cells was reduced (Figures 3H and 3I). Fungal burdens
were also significantly increased in these mice (Figure 3J).
To determine whether IL-23 from the CD301b+ dDCs was
required for dermal gd T cell production of IL-17, we generated
a series of mixed bone marrow chimeras. A 1:1 ratio of bone
marrow isolated from Mgl2-DTR mice and bone marrow from
either WT or Il23a/ mice was transferred into irradiated
CD45.1 mice. After 12 weeks of reconstitution, mice were
treated with either vehicle or DT to generate cohorts in which
CD301b+ dDCs are either IL-23 sufficient or deficient. Mgl2-
DTR+Il23a/ / WT mice in which CD301b+ dDCs are IL-23
deficient demonstrated reduced expression of IL-17 by dermal
gd T cells compared with controls (Figure 4A). The numbers
and proliferation of dermal gd T cells was also reduced (Figuresmunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc. 517
Figure 2. IL-23 Is Required for IL-17 Secretion and Proliferation of Dermal gd T Cells
Micewere infected on their dorsumwith 23 108 CFUsC. albicans. Three days later, single-cell suspensions fromwhole skin was obtained by enzymatic digestion
and subjected to flow cytometry.
(A) Total number of dermal gd T cells in WT or Il23a/ mice is shown in naive (white) or infected (black) mice.
(B) As in (A), cells were re-stimulated with PMA and ionomycin in the presence of monensin and analyzed for IL-17 expression.
(C) The number of IL-17A-expressing dermal gd T cells in (B) is shown in naive (white) or infected (black) mice.
(D) Dermal gd T cells in WT or Il23a/ mice were analyzed for proliferation by nuclear Ki-67 staining compared to naive mice.
(E) C. albicans CFU from day 3 skin homogenates from WT, Il23a/, or Il23a/mice administered 1 mg intradermal recombinant IL-17A (rIL-17A) 1 day prior to
and 1 day after infection.
Error bars represent mean ± SEM. Student’s unpaired t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Data points in (E) represent individual animals.
Data are representative of at least three independent experiments with cohorts of at least six mice.4A–4D). Finally, the CFUs of C. albicans were increased in mice
that lacked IL-23 production from CD301b+ dDCs (Figure 4E).
Thus, CD301b+ dDCs are an obligate source of IL-23 that is
required for activation and expansion of dermal gd T cells during
C. albicans infection.
Nociceptive Neurons Augment Immunity to C. albicans
Cutaneous sensation of temperature and pain is transmitted by
sensory fibers that express the cation channel TRPV1. The role
of nociceptors has been recently appreciated for IL-23-mediated
imiquimod-induced inflammation (Riol-Blanco et al., 2014). In
addition, pathogens such as S. aureus can directly activate neu-
rons isolated from the dorsal root ganglion (DRG) and induce
pain hyper-responsiveness (Chiu et al., 2013). To determine
whether C. albicans could directly affect sensory neurons,
we measured changes in intracellular calcium via intracellular
Fura2-AM fluorescence in primary cultures of mouse DRG neu-
rons exposed to heat-killed C. albicans (HKCA). Cells were stim-
ulated with 30 mM potassium chloride (KCl) initially to determine
viability before being exposed to HKCA (Figure 5A). After a
10 min wash-out period, cells were re-stimulated with 500 mM
of the TRPV1-specific agonist capsaicin (Cap) to assess neu-
ronal specificity. Out of 53 total DRG neurons examined, Cap
induced calcium transients in 24 neurons, identifying them as518 Immunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc.TRPV1+ nociceptors (Figure 5B). Within the group of Cap-sen-
sitive neurons, 17 also responded to HKCA. Furthermore,
zymosan, a yeast cell wall derivative, also directly activated sen-
sory neurons from the DRG (Figure 5C). Thus, the majority
of TRPV1+ neurons are directly activated by C. albicans as
measured by calcium mobilization.
We next examined whether sensory nociceptive fibers partic-
ipated in anti-fungal responses. To ablate TRPV1+ sensory neu-
rons, cohorts of mice were treated subcutaneously with esca-
lating amounts of the capsaicin analog resineferatoxin (RTX)
and rested for 4 weeks (Riol-Blanco et al., 2014). Treated mice
demonstrated increased tail flick latency to heat and absent
nocifensive response to capsaicin administration, confirming
effective ablation of TRPV1+ nociceptors (Figures 5D and 5E).
Mice were then skin infected with C. albicans. RTX-treated
mice demonstrated significantly decreased levels of IL-23 com-
pared with vehicle-treated controls (Figure 5F). In addition, the
numbers IL-17+ dermal gd T cells were reduced and the fungal
burden was increased (Figures 5G–5J).
Recently, TRPV1 has been shown to be expressed and func-
tional on T cells and keratinocytes (Bertin et al., 2014; Graham
et al., 2013). To insure that RTX treatment was not affecting
these cells in addition to nociception, wemechanically disrupted
the cutaneous nerves on one lateral half of the mice dorsum
Figure 3. CD301b+ Dermal DCs Are Required for IL-23-Mediated Protection against C. albicans
CD11c-DTR mice were treated with 1 mg of diphtheria toxin (DT) or vehicle 1 day before infection with 2 3 108 CFU C. albicans.
(A) Il23a expression in whole skin tissue 16 hr after infection as analyzed by qRT-PCR is shown.
(B) C. albicans CFUs in whole skin from control and DC-depleted mice 3 days after infection is shown.
(C–F) Mice lacking LCs and CD103+ dDCs (LCDBatf3D) were infected with C. albicans.
(C) Il23a expression in skin was analyzed 16 hr after infection by qRT-PCR.
(D and E) Number (D) and percent (E) of IL-17A-expressing dermal gd T cells in mice kept naive (white) or infected with C. albicans (black) is shown.
(F) Skin CFUs 3 days after C. albicans infection in LCDBatf3D depleted mice is shown.
(G–J) Mgl2-DTR mice were treated with 1 mg of DT or vehicle 1 day before infection with C. albicans.
(G) Il23a expression in skin was assessed by qRT-PCR 16 hr after infection.
(H and I) Number (H) and percent (I) of IL-17A-expressing dermal gd T cells in mice kept naive (white) or infected with C. albicans (black) is shown.
(J) CFUs in skin 3 days after infection is shown.
Error bars represent mean ± SEM. Student’s unpaired t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Data points in (B), (F), and (J) represent individual
animals. Data are representative of at least three independent experiments with cohorts of at least three animals.(Ostrowski et al., 2011). Infection on the denervated side demon-
strated less Il23a and Il17a mRNA expression as well as higher
fungal burden than the mock denervated side (Figures 5K–5M).
These data indicate that sensory nerves and TRPV1+ nocicep-
tors are crucial for the generation of cutaneous IL-23 and IL-17
responses and protection against C. albicans.
CGRPa Drives IL-23 Expression in CD301b+ dDCs
TRPV1+ neurons release numerous neuropeptides in the periph-
ery (Engel et al., 2011; Meng et al., 2009). Given the importance
of CD301b+ dDCs in our system, we explored the expression
pattern of neuropeptide receptors on cutaneous DC subsets
from data generated by Immunological Genome Consortium
(Miller et al., 2012). Notably, CD11b+ DCs express high levels of
the CGRP receptorsCalrcl andRamp3 (Figure 6A). We confirmed
the microarray findings by analyzing cell surface CALCRL ex-
pression on CD11b+ dDCs by flow cytometry (Figure 6B). This
is consistent with other reports showing expression of CGRP re-
ceptors by CD11b+ DCs in other tissues (Li et al., 2014).
To determine whether sensory neurons released CGRP in
response to C. albicans, we measured CGRP levels after stimu-
lation of cultured DRG neurons with HKCA. HKCA stimulation re-Imsulted in increased concentrations of CGRP in the supernatant of
DRG cultures (Figure 6C) relative to control treatment. Lysates
of HKCA- or control-treated cells had similar concentrations of
CGRP, indicating that the CGRP increase in the supernatant of
HKCA-stimulated cells was not due to HKCA-induced neuronal
damage. Thus, C. albicans directly induce CGRP release from
DRG neurons.
Because ablation of nociception by RTX has been shown to
reduce the expression of CGRP in the skin and because DRGs
exposed to S. aureus supernatant or C. albicans have been
shown to increase CGRP expression in vivo, we next tested
whether CGRP participated in the anti-C. albicans immune
response (Chiu et al., 2013; Hsieh et al., 2012). We found that
daily intradermal administration of CGRPa into the site of
C. albicans infection increased the number of IL-17+ dermal gd
T cells in the skin and reduced the fungal burden. Conversely,
injection of the CGRP antagonist, CGRP32-37, reduced levels of
IL-23, reduced the number of IL-17+ dermal gd T cells in the
skin, and increased the fungal burden (Figures 6D–6F). More-
over, injection of CGRPa in RTX-treatedmice was able to restore
IL-23 expression and fungal burden to levels seen in control mice
(Figures 6F and 6G).munity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc. 519
Figure 4. IL-23 from CD301b+ Dermal DCs Is Necessary for IL-17 Secretion and Proliferation of Dermal gd T Cells
Lethally irradiated B6.SJL-Ly5.2 (CD45.1) mice were re-constituted with 1:1 ratio of bone marrow from Mgl2-DTR mice and either WT or Il23a/ mice. After
12 weeks, mice were treated with 1 mg of diphtheria toxin (DT) or vehicle 1 day before infection with 2 3 108 CFU C. albicans.
(A) IL-17A expression of dermal gd T cells in mice 3 days after C. albicans infection is shown.
(B) The number of IL-17-expressing dermal gd T cells in the skin from (A) is shown.
(C and D) As in (A), Ki-67 staining of dermal gd T cells (C) and quantification of Ki-67+ dermal gd T cells (D) 3 days after infection is shown.
(E) C. albicans skin CFUs from mixed bone marrow chimeric mice 3 days after infection.
Student’s unpaired t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Error bars represent mean ± SEM. Data points in (E) represent individual animals.
Data are representative of at least three independent experiments with cohorts of at least three mice.CGRP, as well as other neuropeptides, have been previously
determined to be directly anti-microbial against C. albicans (Au-
gustyniak et al., 2012; El Karim et al., 2008). To determine
whether CGRP could suppress C. albicans infection indepen-
dently of IL-23-mediated inflammation, we treated CD301b+
depleted Mgl2-DTR mice with CGRPa or vehicle. As shown
previously, DT-treated Mgl2-DTR mice showed reduced IL-23
and an exaggerated fungal burden (Figures 6H and 6I). Unlike
RTX-treated mice, administration of CGRPa to Mgl2-DTR
mice did not rescue the phenotype. Thus, these data indicate
that CGRPa, produced by sensory nerves in response to
C. albicans, acts upstream of CD301b+ dDCs to induce IL-23
expression that induces IL-17 production from dermal gd
T cells, resulting in an effective innate immune response to cuta-
neous C. albicans infection.
DISCUSSION
Our work shows that resistance to C. albicans skin infection
requires IL-17A and identifies dermal gd T cells as the dominant
and primary source of this cytokine. IL-23 derived from CD301+
dDCs was required for proliferation and IL-17A production by
dermal gd T cells. Ablation of dermal gd T cells, CD301b+
dDCs, or selective deletion of IL-23 in CD301b+ dDCs greatly
increased susceptibility to C. albicans skin infection. In addition,
we found that sensory neurons were capable of directly re-
sponding to C. albicans. Ablation of nociceptors or cutaneous520 Immunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc.nerves reduced production of IL-23 from CD301b+ dDCs and
resulted in inefficient clearance of C. albicans through a CGRP-
dependent mechanism. Thus, we have defined a series of coor-
dinated events linking nociceptive sensory neurons, dendritic
cells, and gd T cells that together provide critical host defense
to a fungal pathogen early during skin infection.
Our observation that Il17af/ mice were highly susceptible
to skin infection with C. albicans is consistent with the well-
documented requirement for this cytokine in protection against
C. albicans at barrier surfaces in both humans and mice (Ba¨r
et al., 2014; Conti et al., 2009, 2011, 2014; Conti and Gaffen,
2010; Gladiator et al., 2013; Gladiator and LeibundGut-Land-
mann, 2013; Smeekens et al., 2013; Trautwein-Weidner et al.,
2015). In mice, Th17 cells provide protection from secondary
infection with C. albicans (Herna´ndez-Santos et al., 2013; Ka-
shem et al., 2015). C. albicans is a commensal microorganism
in humans, but not in mice. Thus, protection in naive mice relies
on IL-17 from cells of the innate immune system that can provide
immediate protection rather than Th17 cells that arise only
several days after infection. In the well-studied oropharyngeal
model of mucosal candidiasis, gd T cells, natural IL-17+ ab
T cells, and ILC3s have been demonstrated to be important sour-
ces of IL-17 (Conti et al., 2009, 2014; Gladiator et al., 2013). In the
skin, C. albicans infection induced production of IL-17 primarily
from dermal gd T cells. These cells are also the dominant source
of IL-17 in the response to S. aureus skin infection or imiquimod
application (Cho et al., 2010; Gray et al., 2011, 2013). Ablation of
Figure 5. Nociception and Sensory Nerves Are Crucial Mediators of Anti-fungal Immunity
(A) Sensory neuronswere dissociated fromdorsal root ganglion ofWTmice and cultured for 18–24 hr before being loadedwith the ratiometric intracellular calcium
indicator Fura2-AM. Cultured neurons were stimulated sequentially with 30 mM KCl (10 s), heat-killed 1 3 107 CFU C. albicans (HKCA; 15 s), and 500 mM
capsaicin (Cap; 10 s). Traces showing calcium flux as indicated by the 340/380 ratio visualized bymicroscopy from three individual cells are shown. Dark blue line
represents cell that responded to HKCA and Cap, dotted blue line represents cell that responded to Cap but not HKCA, and red dashed line represents cell that
responded to HKCA but not Cap. Data are representative of 53 cells tested.
(B) Scaled venn diagram representation of the 53 DRG neuron responsiveness to different stimuli.
(C) Cultured neurons were stimulated sequentially with 30 mM KCl (10 s), 1 3 107 CFU zymosan (15 s), and 30 mM KCl (10 s). Traces showing calcium flux as
indicated by the 340/380 ratio visualized by microscopy from a single neuronal cell representative of ten cells.
(D–J) Cohorts of WT mice were injected s.c. with resineferatoxin (RTX) or vehicle (EtOh).
(D) Mice were checked for their latency to tail-flick after submersion in a 52C waterbath.
(E and F) Nocifensive behavior (E) was assessed for 10 min after injection of vehicle or 5 mg of capsaicin into the hindpaws of EtOh- or RTX-treated mice. Neg is
defined as EtOH mice treated with vehicle. Mice were infected with C. albicans and (F) Il23a expression was quantified by qRT-PCR in skin 16 hr later.
(G) IL-17A expression by dermal gd T cells 3 days after infection is shown.
(H and I) The number (H) and percentage (I) of IL-17-expressing dermal gd T cells is shown in naive (white) and infected (black) mice.
(J) C. albicans CFU in vehicle- or RTX-treated mice 3 days after infection is shown.
(K–M) Mice were surgically denervated on one lateral side of their dorsum and infected 7 days later with equal CFUs of C. albicans.
(K and L) Il23a (K) and Il17a (L) expression in skin was quantified by qRT-PCR 16 hr and 60 hr later, respectively.
(M) CFU from mechanically denervated side of infected mice and mock denervated side are shown. Data from individual mice are connected by a line.
Error bars represent mean ± SEM. Student’s unpaired (D–F; H–J) or paired (K–M) t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative
of at least three independent experiments with cohorts of at least five mice.dermal gd T cells increased fungal burden, confirming the impor-
tance of this cell type. We also observed a small subset of IL-17-
producing CD4+ T cells that might represent natural Th17 cells,
but they were not an obligate source of IL-17 in the skin. Notably,
DETCs, ILC3s, and CD8+ T cells that produce IL-17 in other
models were not important sources during C. albicans infection.
Dermal gd T cells constitutively express both subunits of the
receptor for IL-23 and proliferate in response to IL-23 in vitroIm(Cai et al., 2014; Gray et al., 2011). In vivo, both C. albicans
and imiquimod application induce IL-17 production by dermal
gd T cells (Awasthi et al., 2009; Gray et al., 2013). We found
that dermal gd T cells required IL-23 for both induction of IL-17
and proliferation. Notably, although proliferation and IL-17 pro-
duction was greatly diminished in Il23a/ mice, it was not
completely abolished. This might represent a varying require-
ment for IL-23 within heterogeneous populations of dermal gdmunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc. 521
Figure 6. Neuropeptide CGRPa Drives IL-23 Response and Cutaneous Fungal Resistance
(A) Gene expression patterns of CGRP, substance P, neuropeptide Y, somatostatin, and vaso-active intestinal peptide receptors on the indicated skin dendritic
cell subsets. Raw data were obtained from the Immunological Genome Consortium.
(B) Expression of CGRP receptor CALCRL (red) with isotype control (blue) on skin CD11b+ DC subsets.
(C) Cultured DRG neurons were incubated for 10 min in HEPES buffer to measure basal release (Neg) and then incubated for 10 min in HEPES buffer (release,
open bars) or HKCA (release, black bars). CGRP levels in supernatants and cell lysates (lysate) were determined by ELISA.
(D–I) Cohorts of WT mice were treated intradermally with either PBS or 0.5 mg of peptide CGRPa or inhibitor CGRP32-37 on days 1, 0, 1, and 2 of C. albicans
infection.
(D) IL-17A expression of PMA and ionomycin-stimulated dermal gd T cells in mice 3 days after infection is shown.
(E) Skin CFUs 3 days after infection from mice treated with PBS, CGRPa, or inhibitor CGRP32-37 is shown.
(F and G) 4-week-oldWTmice were injected with RTX or vehicle (EtOH) subcutaneously in flank. 4 to 6 weeks later, mice were treated with either PBS, CGRPa, or
inhibitor CGRP32-37.
(F) Expression of Il23a in skin 16 hr after infection was determined by qRT-PCR.
(G) Skin CFUs 3 days after infection is shown.
(H and I) Mgl2-DTR mice were treated with 1 mg of diphtheria toxin (DT) or vehicle 1 day before infection with C. albicans. Mice were given intradermal PBS or
CGRPa on days 1, 0, 1, and 2 of C. albicans infection.
(H) Expression of Il23a in skin 16 hr after infection was assessed by qRT-PCR.
(I) Skin CFU 3 days after infection is shown.
Student’s unpaired t test representative of *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent experiments with cohorts of at
least three mice.T cells. In addition, IL-1b is known to be induced during
C. albicans infection and might be partially sufficient to activate
dermal gd T cells in the absence of IL-23 (Cai et al., 2014; Gray
et al., 2011; Joly et al., 2009).
In both the skin and the small intestine, DCs are the primary
source of IL-23 during inflammation (Igya´rto´ et al., 2011; Kinne-
brew et al., 2012; Wohn et al., 2013; Yoshiki et al., 2014).
We have previously observed that LCs and CD11b+ dDCs pro-
duce much higher levels of IL-23 mRNA than CD103+ dDCs
during C. albicans skin infection (Igya´rto´ et al., 2011). Our cur-
rent observation that mice lacking CD301b+ dDCs (Mgl2-DTR
mice) had reduced levels of IL-23 and reduced resistance
to C. albicans infection coupled with the absence of a pheno-
type in mice lacking both LCs and CD103+ dDCs (LCDBatf3D
mice) argues that CD301b+ dDCs are the source of IL-23.
This was confirmed using mixed bone marrow chimeras in
which CD301b+ dDCs were rendered IL-23 deficient. It is
important to note that CD301b+ dDCs are heterogeneous and
include all CD11b+ conventional DCs in the dermis but also
include populations of CD64+ monocyte-derived DCs and resi-522 Immunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc.dent macrophages (Kashem et al., 2015). The depletion of
CD301b using DTR-depleter mice precluded a definitive identi-
fication of which subset within the CD301b+ population was
required. In support of CD11b+ dDCs, others have found using
Itgax-cre 3 Irf4fl mice that CD11b+ DCs induce IL-17 expres-
sion in skin CD8+ T cells after S. epidermidis colonization and
in lung CD4+ T cells after Aspergillus fumigatus infection (Naik
et al., 2015; Schlitzer et al., 2013). Human homologs of all
these subsets, however, make IL-23 in similar amounts, raising
the possibility that CD301b+ cells other than CD11b+ dDCs
might also contribute IL-23 during C. albicans infection (Haniffa
et al., 2012; Schlitzer et al., 2013).
The interaction of nociceptive neurons and dermal dendritic
cells has recently been appreciated. TRPV1+ nociceptive nerve
fibers in the skin are in close contact with dermal DCs and
are required for their production of IL-23 in the context of imi-
quimod-induced skin inflammation (Riol-Blanco et al., 2014).
Denervation also reduces disease severity in patients with
the IL-17- and IL-23-mediated autoimmune diseases psoriasis
and rheumatoid arthritis, as well as in mouse models of these
diseases (Joseph et al., 2005; Thompson and Bywaters, 1962;
Ostrowski et al., 2011; Riol-Blanco et al., 2014; Stangenberg
et al., 2014). Patients with spinal cord injuries have decreased
levels of IL-23 and IL-17 as well as frequent fungal skin infections
below the site of neurological lesion (Jones and Jones, 2014;
Nash, 2000; Rubin-Asher et al., 2005). In addition, the skin path-
ogen S. aureus directly activates sensory nerves resulting in
hyper-responsiveness to pain, and the yeast cell wall product,
zymosan, has been used extensively to experimentally induce
pain (Chiu et al., 2013; Ren and Dubner, 1999).
Our data connect these observations and demonstrate
that sensory neurons can directly sense a pathogen and then
enhance host resistance via secretion of neuropeptides. We
found that CD301b+ dDCs have reduced expression of IL-23
after RTX ablation of TRPV1+ neurons or physical denervation
resulting in reduced gd T cell activation and reduced resistance
to C. albicans infection. Expression of IL-23 and host defense
could be inhibited by administering the CGRP peptide antago-
nist, CGRP32-37, and augmented by the addition of the CGRP
agonist, CGRPa. Moreover, CGRPa rescued IL-23 responses
in RTX-treated WT mice but did not rescue mice lacking
CD301b+ dDCs, indicating that CGRPa does not directly inhibit
C. albicans proliferation or function indirectly through other
cell types such as keratinocytes or fibroblasts (Roggenkamp
et al., 2013). Thus, CGRPa acts downstream of TRPV1+ noci-
ceptors but acts upstream of CD301b+ dDCs. Notably, cultured
DRGs were able to flux calcium and release CRGP in res-
ponse to exposure to C. albicans. Many of these DRG neurons
were also capsaicin responsive, which is consistent with
the observed reduction of anti-C. albicans responses in RTX-
treated mice. Capsaicin-insensitive DRGs also responded to
C. albicans, suggesting that other sensory neurons might also
participate in the anti-C. albicans response. Although our data
indicate that C. albicans can directly activate sensory neurons
in DRG cultures, it does not negate the likely role of inflamma-
tion-induced pain response or indirect activation of nociceptors
in vivo.
We focused on CGRP rather than other neuropeptides
based on the high expression levels of CGRP receptors on
CD11b+ dDCs and the ability of C. albicans to directly induce
CGRP release by DRG neurons. In the lung, these DCs also ex-
press CGRP receptors and promote airway hyperresponsive-
ness (Li et al., 2014). In murine vulvovaginal candidiasis, pain
was accompanied by increased expression of CGRP in peri-
pheral nerves (Farmer et al., 2011). In addition, CGRP has also
been implicated in the pathogenesis of psoriasis (Assas et al.,
2014; Saraceno et al., 2006). It is important to note that although
our data highlight the importance of CGRPa, we have not
excluded a role for other neuropeptides in host defense against
C. albicans.
In summary, we have elucidated a mechanism of innate host
defense against C. albicans infection in the skin that involves
pain-sensing neurons, dermal dendritic cells, and dermal gd
T cells as well as the soluble factors CGRPa, IL-23, and IL-17.
This work provides insight into the complex interplay of cells of
the innate immune system at a barrier tissue and offers potential
avenues of therapeutic interventions to suppress IL-23- and/or
IL-17-mediated autoimmune skin diseases and augment antimi-
crobial therapy.ImEXPERIMENTAL PROCEDURES
Mice
Mgl2eGFP-DTR/wt (referred to as Mgl2-DTR), human Langerin-DTA3Batf3/
(referred to as LCDBatf3D), CD11c-DTR, Rag1/, Tcra/, Tcrd/, Il23a/,
and Il17af/ mice have been previously described (Edelson et al., 2010; Ghi-
lardi et al., 2004; Haas et al., 2012; Itohara et al., 1993; Jung et al., 2002; Kaplan
et al., 2005; Kumamoto et al., 2013; Mombaerts et al., 1992a, 1992b; Welty
et al., 2013). See Supplemental Experimental Procedures for additional details.
Generation and Testing of Bone Marrow Chimeric Mice
Recipient mice received two split doses at 500 cGy each followed by 5 3 106
bone marrow donor cells 24 hr later. See Supplemental Experimental Proce-
dures for additional details.
DC Depletion with Diphtheria Toxin
CD11c-DTR andMgl2-DTRmice were i.p. injected with 1 mg of diphtheria toxin
(List Biological Laboratories) 1 day before infection.
Flow Cytometry
Single-cell skin suspensions and flow cytometry were performed as previously
described (Kashem et al., 2015). Antibodies used in study and detailed
methods are further described in the Supplemental Experimental Procedures.
qPCR
Isolation of RNA and qPCR was performed as previously described (Kashem
et al., 2015). Detailed methods are further described in the Supplemental
Experimental Procedures.
Candida albicans Strains
Growth of C. albicans strain SC5314 occurred after inoculation of a colony at
30C in YPAD overnight and, the next day, diluted 1:10 and cultured in 30C in
YPAD until OD600 reached 1.5 and then washed and re-suspended at 43 10
9
CFU/ml in PBS.
Infection Models
The skin infection was performed as described (Haley et al., 2012; Igya´rto´
et al., 2011) and is fully described in the Supplemental Experimental Proce-
dures. In some instances, CGRPa or CGRP32-37 (Genscript) was administered
intradermally at days 1, 0, 1, and 2 during infection at total 0.5 mg per dose
spread over 10 sites in the back. When specified, 1.0 mg recombinant IL-17A
(R&D Biosystems) was administered on days 1 and 1 during infection.
Denervation
Ablation of nociception was obtained using resineferatoxin (RTX; LC Labora-
tories) as previously described (Riol-Blanco et al., 2014). Mechanical dener-
vation was performed as previously described (Ostrowski et al., 2011;
Siebenhaar et al., 2008). Both are further described in the Supplemental Exper-
imental Procedures.
Behavioral Assays
Ethanol- or resineferatoxin-treated mice were rested 24 hr prior to experiment
to allow for adjustment to the experimenter before behavioral assessment as-
says. Responsiveness to noxious heat stimuli was performed as previously
described (Bannon and Malmberg, 2007). Assay is further described in the
Supplemental Experimental Procedures.
DRG Cultures
Primary cultures of mouse DRG neurons were prepared using methods similar
to those previously described (Khasabova et al., 2002). In brief, DRG were
enzymatically dissociated in Collagenase-D (1.5 mg/ml, two 60 min incuba-
tions; Roche Diagnostics), filtered, and plated onto poly-l-lysine coverslips.
See Supplemental Experimental Procedures for additional details.
Calcium Imaging
In brief, 18–24 hr after plating onto coverslips, cells were incubated in the ra-
tiometric intracellular calcium indicator, Fura2-AM (Invitrogen Life Technolo-
gies) at 37C for 1 hr. Coverslips were then transferred to a recording chambermunity 43, 515–526, September 15, 2015 ª2015 Elsevier Inc. 523
and cells were stimulated with 30 mM KCl (10 s), heat-killed 1 3 107 Candida
albicans (15 s), and 500 mM capsaicin (10 s) or 30 mM KCl (10 s). Excitation
wavelengths (340- and 380-nm) were used to calculate calcium flux. See Sup-
plemental Experimental Procedures for additional details.
CGRP Release Assay
After 48 hr in culture, DRG neurons (approx. 20,000 cells/well) were washed
once with HEPES buffer and then incubated in HEPES buffer for 10 min (for
measurement of basal release) followed by a 10 min incubation with HEPES
or HKCA resuspended in HEPES buffer (for measurement of stimulated
release). CGRP levels in the supernatant were measured by ELISA (Cayman
Chemical). See Supplemental Experimental Procedures for additional details.
Microarray Gene Expression Data for Murine Skin DC Subsets
Microarray gene expression data for three murine skin DC subsets (with repli-
cates) was obtained from the Immunological Genome Consortium (Heng et al.,
2008; Miller et al., 2012). To analyze gene expression data, we log transformed
normalized levels as provided in the original publication and databases. We
used median expression to summarize microarray probe-level data and
used average expression values between replicates of each DC subset. For
visualization, we z-transformed the data.
Statistics and Data Representation
Results are presented asmean ± standard error unless noted and groups were
compared by unpaired Student’s t test using GraphPad Prism software. See
Supplemental Experimental Procedures for additional details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and can be found with this article online at http://dx.doi.org/10.1016/j.
immuni.2015.08.016.
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